Publicação

Detection of the Prostate Cancer Biomarker PCA3 with Electrochemical and Impedance-Based Biosensors

Detalhes bibliográficos
Resumo:	Diagnosis of prostate cancer via PCA3 biomarker detection is promising to be much more efficient than with the prostatic specific antigens currently used. In this study, we present the first electrochemical and impedance-based biosensors that are capable of detecting PCA3 down to 0.128 nmol/L. The biosensors were made with a layer of PCA3-complementary single-stranded DNA (ssDNA) probe, immobilized on a layer-by-layer (LbL) film of chitosan (CHT) and carbon nanotubes (MWCNT). They are highly selective to PCA3, which was confirmed in impedance measurements and with polarization-modulated infrared reflection absorption spectroscopy (PM-IRRAS). Using information visualization methods, we could also distinguish between cell lines expressing the endogenous PCA3 long noncoding RNA (lncRNA) from cells that did not contain detectable levels of this biomarker. Since the methods involved in fabrication the biosensors are potentially low cost, one may hope to deploy PCA3 tests in any laboratory of clinical analyses and even for point-of-care diagnostics.
Autores principais:	Soares, Juliana Coatrini
Outros Autores:	Soares, Andrey Coatrini; Rodrigues, Valquiria Cruz; Melendez, Matias Eliseo; Santos, Alexandre Cesar; Faria, Eliney Ferreira; Reis, R. M.; Carvalho, Andre Lopes; Oliveira, Osvaldo N.
Assunto:	Antigens, Neoplasm Biomarkers, Tumor Cell Line, Tumor DNA, Single-Stranded Dielectric Spectroscopy Humans Male Nanotubes, Carbon Prostate Prostate-Specific Antigen Prostatic Neoplasms RNA, Long Noncoding Biosensing Techniques Biosensors prostate cancer PCA3 Impedance spectroscopy EIS DNA biosensors prostate cancer Ciências Médicas::Medicina Básica
Ano:	2019
País:	Portugal
Tipo de documento:	artigo
Tipo de acesso:	acesso restrito
Instituição associada:	Universidade do Minho
Idioma:	inglês
Origem:	RepositóriUM - Universidade do Minho

Registos relacionados

Elevated prostate volume index and prostatic chronic inflammation reduce the number of positive cores at first prostate biopsy set: results in 945 consecutive patients
por: Porcaro,Antonio B.
Publicado em: (2020)

Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysis
por: Fontenete,S.
Publicado em: (2011)

Metastatic prostate cancer in the modern era of PSA screening
por: Fontenot Jr,Philip A.
Publicado em: (2017)

High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer
por: Lobo, João
Publicado em: (2018)

Prostate-Specific Antigen fluctuation: what does it mean in diagnosis of prostate cancer?
por: Kim,Jun Seok
Publicado em: (2015)

Testing the variability of PSA expression by different human prostate cancer cell lines by means of a new potentiometric device employing molecularly antibody assembled on graphene surface
por: Rebelo, Tânia S.C.R.
Publicado em: (2016)

Retrospective study comparing six - and twelve-core prostate biopsy in detection of prostate cancer
por: Tobiume,Motoi
Publicado em: (2008)

Value of prostate specific antigen in predicting the existence of bone metastasis in scintigraphy
por: Rhoden,Ernani L.
Publicado em: (2003)

PCA3 rs544190G>A and prostate cancer risk in an eastern Chinese population
por: Cao,Dalong
Publicado em: (2018)

Integrated predictive model for prostatic cancer using clinical, laboratory and ultrasound data
por: LUDWIG,GUSTAVO DAVID
Publicado em: (2016)

Outcomes following negative prostate biopsy for patients with persistent disease after radiotherapy for prostate cancer
por: Cohen,Jacob H.
Publicado em: (2010)

Assessment of serum level of prostate-specific antigen adjusted for the transition zone volume in early detection of prostate cancer
por: Ferreira,Marcos D.
Publicado em: (2005)

Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and 10 ng/ml
por: Gregorio,Emerson P.
Publicado em: (2007)

Predictive value of [-2]propsa (p2psa) and its derivatives for the prostate cancer detection in the 2.0 to 10.0ng/mL PSA range
por: Vukovic,I.
Publicado em: (2017)

Pretreatment tumor volume estimation based on total serum psa in patients with localized prostate cancer
por: Kato, Raphael Barroso
Publicado em: (2008)

Are prostate carcinoma clinical stages T1C and T2 similar?
por: Billis,Athanase
Publicado em: (2006)

Is there any association between National Institute of Health category IV prostatitis and prostate-specific antigen levels in patients with low-risk localized prostate cancer?
por: Doluoglu,Omer Gokhan
Publicado em: (2016)

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome
por: Pereira-Azevedo, Nuno
Publicado em: (2018)

Racial influence on the prevalence of prostate carcinoma in Brazilian volunteers
por: Paschoalin,Edson L
Publicado em: (2003)

Prevalence of prostate adenocarcinoma according to race in an university hospital
por: Barros,Milton S
Publicado em: (2003)

Predictive value of PSA velocity over early clinical and pathological parameters in patients with localized prostate cancer who undergo radical retropubic prostatectomy
por: Martinez,Carlos A.L.
Publicado em: (2004)

Value of various PSA parameters for diagnosing prostate cancer in men with normal digital rectal examination
por: Miotto Jr,Ari
Publicado em: (2004)

Prostate cancer pathologic stage pT2b (2002 TNM staging system): does it exist?
por: Quintal,Maisa M.
Publicado em: (2006)

Prostatic specific antigen for prostate cancer detection
por: Nogueira,Lucas
Publicado em: (2009)

Efficacy of Leuprorelide acetate (Eligard®) in daily practice in Brazil: a retrospective study with depot formulations in patients with prostate cancer
por: Freitas,Carla S. M. de
Publicado em: (2020)

Clinical utility of prostate-specific antigen mass ratio for prediction of prostate cancer detection on a repeated prostate biopsy
por: Lee,Won Ki
Publicado em: (2014)

A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice?
por: Araújo,Fernando Antônio Glasner da Rocha
Publicado em: (2019)

PSA density of the lesion: a mathematical formula that uses clinical and pathological data to predict biochemical recurrence in prostate cancer patients
por: JUNQUEIRA,PEDRO HENRIQUE REZENDE
Publicado em: (2021)

Assessment of PSA-Age volume score in predicting positive prostate biopsy findings in Turkey
por: Uçer,Oktay
Publicado em: (2015)

The novel prostate cancer antigen 3 (PCA3) biomarker
por: Bourdoumis,Andreas
Publicado em: (2010)

Changes observed in prostate biopsy practices in an inner city hospital with a high risk patient population following the 2012 USPSTF PSA screening recommendations
por: Tam,Andrew W.
Publicado em: (2018)

Prostate-specific antigen levels in patients with risk factors for prostate carcinoma disorders
por: Terreros,Mercedes
Publicado em: (2020)

Correlation of hepatitis C and prostate cancer, inverse correlation of basal cell hyperplasia or prostatitis and epidemic syphilis of unknown duration
por: Krystyna,Annika
Publicado em: (2011)

Biochemical recurrence after radical prostatectomy: what does it mean?
por: Tourinho-Barbosa,Rafael
Publicado em: (2018)

PSA kinetics before 40 years of age
por: Pazeto,Cristiano Linck
Publicado em: (2018)

Does index tumor predominant location influence prognostic factors in radical prostatectomies?
por: Billis,Athanase
Publicado em: (2017)

Serum PSA and cure perspective for prostate cancer in males with nonpalpable tumor
por: Dall'Oglio,Marcos F.
Publicado em: (2005)

The prostate health index (PHI) density : are there advantages over PHI or over the prostate-specific antigen density?
por: Garrido, Manuel Matos
Publicado em: (2021)

The prostate health index (PHI) density: Are there advantages over PHI or over the prostate-specific antigen density?
por: Garrido, MM
Publicado em: (2021)

Survival of patients with prostate cancer and normal PSA levels treated by radical prostatectomy
por: Dall'oglio,Marcos F.
Publicado em: (2005)

Atividades financiadas

Não foram encontrados projetos financiados.